A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD

Clinical trial NCT06208306 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06208306
Sponsor: Sanofi
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2024-01-11
Primary completion: 2026-12-01
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.